4D Molecular Therapeutics (FDMT) EBIT Margin (2020 - 2026)
4D Molecular Therapeutics (FDMT) recorded EBIT Margin of -2037.16% in Q2 2026, up 394336.17 percentage points from -396373.33% a year earlier and up 378.99 percentage points from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) EBIT Margin (2020 - 2026) Analysis & Trends
On a TTM basis, 4D Molecular Therapeutics' EBIT Margin came in at -214.24% as of Jun 30, 2026, up 667440.31 percentage points year-over-year; for FY2025, it was -187.24%, up 507491.14 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of +229.04 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -507678.38% in FY2024 (-507133.73 pp), -544.65% in FY2023 (+2971.88 pp), -3516.52% in FY2022 (-3121.06 pp) and -395.46% in FY2021 (+20.82 pp).
- Quarterly EBIT Margin has ranged from -5611700.00% in Q4 2024 to 17.29% in Q4 2025 over the past five years.
- On a year-over-year basis, EBIT Margin has increased for five consecutive quarters, with an average year-over-year change of +932095.69 percentage points over the last seven quarters.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 5611717.29 percentage points in Q4 2025, against a drop of 1704330.84 percentage points in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -2416.15% (Q1 2026), 17.29% (Q4 2025) and -67983.33% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | -2,037.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,037.16% |
| Mar 31, 2026 | -2,416.15% |
| Dec 31, 2025 | 17.29% |
| Sep 30, 2025 | -67,983.33% |
| Jun 30, 2025 | -396,373.33% |
| Mar 31, 2025 | -383,007.14% |
| Dec 31, 2024 | -5,611,700.00% |
| Sep 30, 2024 | -1,704,400.00% |
| Jun 30, 2024 | -849,120.00% |
| Mar 31, 2024 | -136,200.00% |
| Sep 30, 2023 | -69.16% |
| Jun 30, 2023 | -13,446.03% |
| Mar 31, 2023 | -10,102.68% |
| Dec 31, 2022 | -2,303.13% |
| Sep 30, 2022 | -5,299.00% |
| Jun 30, 2022 | -17,546.91% |
| Mar 31, 2022 | -2,165.05% |
| Dec 31, 2021 | -26,917.39% |
| Sep 30, 2021 | -1,658.93% |
| Jun 30, 2021 | -52.10% |
API Access
4D Molecular Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();